Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Uterine Immune Profiling and Personalized Treatments on Subsequent Live Birth in Patients Receiving a Single Blastocyst: a Matched Controlled Study

NCT06503952 is registered in ClinicalTrials.gov with Matricelab Innove as lead sponsor.

NCT NCT06503952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06503952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Uterine Immune Profiling and Personalized Treatments on Subsequent Live Birth in Patients Receiving a Single Blastocyst: a Matched Controlled Study
Lead sponsor
Matricelab Innove
Phase
Observational
Overall status
Not yet recruiting
Start date
January 15, 2025
Completion date
May 30, 2025
Enrollment
340 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

immune system, immunological tolerance, infertility, pregnancy outcomes, single embryo transfer, success rate of assisted reproductive therapy